$17.51
-0.25-1.41%
At Close: -
$17.52
0.01000.06%
After Hours: 5:22 PM EDT
15 minutes delayed
Teva Pharmaceutical Indus reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Teva Pharmaceutical Indus using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $0.61 | $0.55 | 10.9 % |
Mar 2024 | 2024-05-08 | $0.48 | $0.51 | -5.88 % |
Dec 2023 | 2024-01-31 | $1.00 | $0.77 | 29.9 % |
Sep 2023 | 2023-11-08 | $0.60 | $0.61 | -1.64 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $4.16B | $4.06B | 2.56 % |
Mar 2024 | 2024-05-08 | $3.82B | $3.73B | 2.39 % |
Dec 2023 | 2024-01-31 | $4.46B | $4.01B | 11.2 % |
Sep 2023 | 2023-11-08 | $3.85B | $3.72B | 3.49 % |
Teva Pharmaceutical Indus (TEVA) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on July 31, 2024 for Q2.
The Actual EPS was $0.61, which beat the estimate of $0.55.
The Actual Revenue was $4.2B, which beat the estimate of $4.1B.
Browse earnings estimates, EPS, and revenue on all stocks.